Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:00:00 on US and Canada Markets.
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023 PR Newswire Conference call scheduled for 9:00 AM ET ...
Total deal size of approximately ~$650M, including over $150M in upfront and near-term milestones Neuraxpharm’s dedicated neurology focus and established European presence makes them an attractive partner for BRIUMVI’s European launch, targeted within the next six months ...
SiriusXM Reports Second Quarter 2023 Operating and Financial Results PR Newswire NEW YORK , Aug. 1, 2023 /PRNewswire/ -- SiriusXM (NASDAQ: SIRI) today reported operating and financial results for the second quarter 2023, which have been posted to the Investor Rel...
TARRYTOWN, N.Y., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 11th annual Regeneron Prize for Creative Innovation, a competition designed to honor exceptional talent and originality in biomedical research. Each year, Regeneron...
Agreement provides ProQR with initial payment of €12.5M and up to €135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU Divestment of sepofarsen and ultevursen supports ProQR’s strategic focus on the Axiomer&...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 3:00 p.m. ET. An audio webcast of the presentation will be available...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on August 8, 2023 at 8:30 a.m. ET to discuss second quarter results and provide a general business update. To access the con...
THE WOODLANDS, Texas, Aug. 01, 2023 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the second quarter 2023 and the six months ended June 30, 2023. Second Quarter 2023 Highlights Net Income of $53.1 million,...
Total net product revenues of $827 million in the second quarter (Q2'23) (+25% Y/Y) Jakafi ® (ruxolitinib) net product revenues of $682 million (+14% Y/Y) in Q2'23; raising the bottom end of full year guidance to a new range of $2.58 - $2.63 billion for FY 2023 Opzelura ...
Highlights (All comparisons are to the prior year period unless otherwise noted) : Net sale s of $480.6 million, up 15% Diluted earnings per share (“EPS”) of $1.04, compared to $1.20 Adjusted diluted EPS* of $1.01, compared to ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
25.54%Change Percent:
Locafy Limited Company Name:
LCFY Stock Symbol:
NASDAQ Market:
locafy.com Website: